Terms: = Gastric cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Diagnosis
12 results:
1. Investigating fgfr2 gene as a blood-based epigenetic biomarker in gastric cancer.
Aleyasin SA; Moradi A; Abolhasani N; Abdollahi M
Mol Biol Rep; 2024 Feb; 51(1):253. PubMed ID: 38302798
[TBL] [Abstract] [Full Text] [Related]
2. gastric carcinosarcoma with fgfr2 amplification under long-term control with pazopanib: a case report and literature review.
Hayashi H; Makiyama A; Okumura N; Yasufuku I; Saigo C; Takeuchi T; Miyazaki T; Tanaka Y; Matsuhashi N; Murase K; Takahashi T; Futamura M; Yoshida K
BMC Gastroenterol; 2022 Jul; 22(1):360. PubMed ID: 35902814
[TBL] [Abstract] [Full Text] [Related]
3. The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced gastric cancer in Asia.
Nakamura Y; Shitara K; Lee J
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-8. PubMed ID: 34010049
[TBL] [Abstract] [Full Text] [Related]
4. MiRNA-200c, MiRNA-139 and ln RNA H19; new predictors of treatment response in H-pylori- induced gastric ulcer or progression to gastric cancer.
Schaalan M; Mohamed W; Fathy S
Microb Pathog; 2020 Dec; 149():104442. PubMed ID: 32795593
[TBL] [Abstract] [Full Text] [Related]
5. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
[TBL] [Abstract] [Full Text] [Related]
6. Mutually exclusive fgfr2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH.
Das K; Gunasegaran B; Tan IB; Deng N; Lim KH; Tan P
Cancer Lett; 2014 Oct; 353(2):167-75. PubMed ID: 25086186
[TBL] [Abstract] [Full Text] [Related]
7. Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.
Lee J; Ou SH
Discov Med; 2013 Aug; 16(86):7-14. PubMed ID: 23911227
[TBL] [Abstract] [Full Text] [Related]
8. Clinical significance of keratinocyte growth factor and k-sam gene expression in gastric cancer.
Tani H; Saito N; Kobayashi M; Kameoka S
Mol Med Rep; 2013 May; 7(5):1381-6. PubMed ID: 23545898
[TBL] [Abstract] [Full Text] [Related]
9. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
Dulak AM; Schumacher SE; van Lieshout J; Imamura Y; Fox C; Shim B; Ramos AH; Saksena G; Baca SC; Baselga J; Tabernero J; Barretina J; Enzinger PC; Corso G; Roviello F; Lin L; Bandla S; Luketich JD; Pennathur A; Meyerson M; Ogino S; Shivdasani RA; Beer DG; Godfrey TE; Beroukhim R; Bass AJ
Cancer Res; 2012 Sep; 72(17):4383-93. PubMed ID: 22751462
[TBL] [Abstract] [Full Text] [Related]
10. Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.
Yamashita K; Sakuramoto S; Watanabe M
Surg Today; 2011 Jan; 41(1):24-38. PubMed ID: 21191688
[TBL] [Abstract] [Full Text] [Related]
11. Molecular mechanisms of carcinogenesis in gastric cancer.
Höfler H; Becker KF
Recent Results Cancer Res; 2003; 162():65-72. PubMed ID: 12790321
[TBL] [Abstract] [Full Text] [Related]
12. The use of molecular biology in diagnosis and prognosis of gastric cancer.
Becker KF; Keller G; Hoefler H
Surg Oncol; 2000 Jul; 9(1):5-11. PubMed ID: 11525306
[TBL] [Abstract] [Full Text] [Related]
